Epidemiology of atrial fibrillation in Turkey: preliminary results of the multicenter AFTER study

References (5)

1. Ertaş F, Kaya H, Kaya Z, Bulur S, Köse N, Gul M, et al. Epi- demiology of atrial fibrillation in Turkey: preliminary results of the multicenter AFTER study. Türk Kardiyol Dern Arş 2013;41:99-104
2. Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, et al. Should patient characteristics influ- ence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Circ Cardio- vasc Qual Outcomes 2009;2:297-304
3. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohn- loser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. De- veloped with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719-47
4. Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, et al. Benefit of oral anticoagulant over anti- platelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circula- tion 2008;118:2029-37
5. İncesoy N, Fıratlı İ, Turkoglu C, Ozturk M. Türkiye'de atri- yal fibrilasyonlu olgularda oral antikoagülan kullanımı. Turk Kardiyol Dern Ars 2000;28:534-537.